Introduction: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality. In the gulf countries specially in Saudi
Arabia Diabetes type 2 is becoming the highest in the world, affecting around 30% of adults. In fact, diabetes is associated with an
increased risk of cardiovascular disease (CVD). The management of high lipid levels in diabetes is a key aspect within the
multifactorial technique to save CVD in people with type 2 diabetes. Several meta-analysis studies have in reality validated the
effects of statin remedy. Aims: To look into the adherence of simvastatin in patients with type 2 diabetes. Methods: A descriptive case
looking at 1680 diabetic patients conducted in Hera General Hospital. Data were retrieved from clinical files from January 2018 until
December 2018. Data evaluation performed using the SPSS software. Results: Almost 95 percent of the population around was older
than 45 years. Almost all patients (97%) were on statin therapy. Treatment goal for an LDL less than 2.5 mmol/l was found in (20%)
patients. Diabetic men were more likely than diabetic women to receive a statin prescription (P<0.05). Conclusion: Data from 2018
showed that diabetic HGH patients showed only a small proportion of patients with diabetes have met the LDL treatment goal this
was mainly because of poor adherence. This underline the need for better monitoring, better use of available medicines and new
treatment options for better quality of life.
Keywords: Simvastatin, Diabetes type 2, CVD, Dyslipidemia.